MedTrace Logo

Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery

NCT05754944 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2026-03-04

No results posted yet for this study

Summary

Researchers are studying whether people with risk factors for blood circulation disease have a condition called peripheral arterial disease (PAD). People with PAD have poor blood circulation because of narrowing or blocks in blood vessels caused by fat or calcium deposits (atherosclerosis). The study researchers think that PAD may lead to worse outcomes in cancer treatment, but people with cancer are not routinely tested for the disease.

The purpose of this study is to find out how common PAD is among people with cancer who have risk factors for blood circulation disease, and to compare how often PAD is diagnosed in different racial groups

Conditions

  • Peripheral Arterial Disease (PAD) in Cancer Patients

Interventions

DIAGNOSTIC_TEST

ABI/TBI

ABI/TBI to be performed after surgery while patient is still admitted at the hospital.

OTHER

Questionnaires

PAD symptoms questionnaire to be administered at baseline before surgery. mLEFS (included in PAD symptoms questionnaire) and WIQ to be administered at baseline before surgery. mLEFS and WIQ will be administered 1 month, 3 months, 6 months after surgery and every 6 months after that for a goal of at least 1 year.

Sponsors & Collaborators

Principal Investigators

  • Yolanda Bryce, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-22
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05754944 on ClinicalTrials.gov